Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial

Abstract Induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) is the standard treatment for locoregionally advanced nasopharyngeal carcinoma (LA-NPC); however, patients with a suboptimal response to IC, defined as detectable Epstein–Barr virus DNA and/or stable or progressive...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Li-Ting Liu, Xue-Song Sun, Ting-Ting Quan, Xiao-Yun Li, Ling Guo, Hao-Yuan Mo, Shan-Shan Guo, Sai-Lan Liu, Ying Huang, Dong-Hua Luo, Rui Sun, Guo-Dong Jia, Ji-Bin Li, Qing Liu, Pan Wang, Yu-Jing Liang, Jie Chen, Yi-Fu Li, Hui Cheng, Wei-Xiong Xia, Fang Qiu, Jin-Hao Yang, Qi Yang, Dong-Xiang Wen, Jin-Jie Yan, Chong Zhao, Qiu-Yan Chen, Lin-Quan Tang, Hai-Qiang Mai
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2026-03-01
Edice:	Nature Communications
On-line přístup:	https://doi.org/10.1038/s41467-026-71019-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!